Safety and efficacy of vismodegib and impact of treatment breaks in advanced basal cell carcinoma: Interim analysis of the STEVIE study in 499 patients

被引：0
|
作者：
Kuntsfeld, Rainer [1 ]
Grob, Jean-Jacques [2 ]
Mortier, Laurent [3 ]
Ascierto, Paolo Antonio [4 ]
Guillot, Bernard [5 ]
Williams, Sarah [6 ]
Xynos, Ioannis [6 ]
Basset-Seguin, Nicole [7 ]
Hansson, Johan [8 ]
Hauschild, Axel [9 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Timone Hosp, Marseille, France
[3] Univ Lille 2, Lille, France
[4] Ist Nazl Tumori Fondaz G Pascale, Naples, Italy
[5] Univ Hosp Montpellier, Montpellier, France
[6] Roche Prod Ltd, Welwyn Garden City, Herts, England
[7] Univ Paris 07, Paris, France
[8] Karolinska Inst, Stockholm, Sweden
[9] Univ Hosp Schleswig Holstein, Kiel, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
3122
引用
收藏
页码：AB204 / AB204
页数：1
相关论文
共 50 条
  • [1] Updated STEVIE interim analysis of Hedgehog pathway inhibitor, vismodegib, in 300 patients with advanced basal cell carcinoma
    Grob, J. -J
    Kunstfeld, R.
    Dreno, B.
    Jouary, T.
    Mortier, L.
    Ascierto, P.
    Basset-Seguin, N.
    Hansson, J.
    Mitchell, L.
    Starnawski, M.
    Hauschild, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 107 - 108
  • [2] Vismodegib, a Hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study interim analysis in 300 patients
    Grob, Jean Jacques
    Kunstfeld, Rainer
    Dreno, Brigitte
    Jouary, Thomas
    Mortier, Laurent
    Basset-Seguin, Nicole
    Ascierto, Paolo Antonio
    Hansson, Johan
    Mitchell, Lada
    Starnawski, Michal
    Hauschild, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] STEVIE (Safety Events In VIsmodEgib), a single-arm, open-label study on the safety of Hedgehog Pathway Inhibitors in advanced basal cell carcinoma Vismodegib: interim analysis of 150 patients
    Gutzmer, Ralf
    Leverkues, Martin
    Garbe, Claus
    Herbst, Rudolf
    Schadendorf, Dirk
    Kunstfeld, Rainer
    Hansson, Johan
    Basset-Seguin, Nicole
    Page, Damian
    Mitchell, Lada
    Hauschild, Axel
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 677 - 677
  • [4] Efficacy and safety of vismodegib in advanced basal cell carcinoma
    Chang, A.
    Sekulic, A.
    Migden, M. R.
    Hauschild, A.
    Lewis, K.
    Hainsworth, J. D.
    Yoo, S.
    Dirix, L.
    Hou, J.
    Mackey, H.
    Oro, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S93 - S93
  • [5] Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
    Spallone, Giulia
    Sollena, Pietro
    Ventura, Alessandra
    Fargnoli, Maria C.
    Gutierrez, Carlota
    Piccerillo, Alfredo
    Tambone, Sara
    Bianchi, Luca
    Peris, Ketty
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [6] Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
    Sekulic, Aleksandar
    Migden, Michael R.
    Oro, Anthony E.
    Dirix, Luc
    Lewis, Karl D.
    Hainsworth, John D.
    Solomon, James A.
    Yoo, Simon
    Arron, Sarah T.
    Friedlander, Philip A.
    Marmur, Ellen
    Rudin, Charles M.
    Chang, Anne Lynn S.
    Low, Jennifer A.
    Mackey, Howard M.
    Yauch, Robert L.
    Graham, Richard A.
    Reddy, Josina C.
    Hauschild, Axel
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23): : 2171 - 2179
  • [7] Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
    Basset-Seguin, Nicole
    Hauschild, Axel
    Grob, Jean-Jacques
    Kunstfeld, Rainer
    Dreno, Brigitte
    Mortier, Laurent
    Ascierto, Paolo A.
    Licitra, Lisa
    Dutriaux, Caroline
    Thomas, Luc
    Jouary, Thomas
    Meyer, Nicolas
    Guillot, Bernard
    Dummer, Reinhard
    Fife, Kate
    Ernst, D. Scott
    Williams, Sarah
    Fittipaldo, Alberto
    Xynos, Ioannis
    Hansson, Johan
    LANCET ONCOLOGY, 2015, 16 (06): : 729 - 736
  • [8] Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate the safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma
    Lear, J. T.
    Gore, M.
    Guerrero-Urbano, T.
    Herd, R.
    Plummer, R.
    Basset-Seguin, N.
    Hansson, J.
    Mitchell, L.
    Starnawski, M.
    Hauschild, A.
    Fife, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 : 2 - 2
  • [9] Interim analysis of STEVIE, a single-arm, open-label, multicentre study to evaluate the safety of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma
    Lear, J.
    Fife, K.
    Gore, M.
    Guerrero-Urbano, T.
    Herd, R.
    Plummer, R.
    Seguin, N. Basset
    Hansson, J.
    Mitchell, L.
    Starnawski, M.
    Hauschild, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 3 - 3
  • [10] The efficacy of vismodegib in treatment of advanced basal cell carcinoma - An analysis of a case series
    Delli, F. S.
    Sidiropoulos, T.
    Kampouropoulou, E.
    Papageorgiou, M.
    Efthimiadis, K.
    Lefaki, I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 89 - 89
12345